About ILD Program

​​​​The Hamdi Al Zaim Interstitial Lung Disease (ILD) Program is dedicated to improving the lives of patients with interstitial lung disease, or ILD. We provide state-of-the -art diagnosis and treatment recommendations, by working as a multidisciplinary team to review each case thoroughly and to optimize disease and symptom management. 

The program delivers a comprehensive and holistic care for patients with all types of ILD. We do this by focusing on patient care, education and research, and community building. ILD team communicate directly with patients and their referring doctors to assure continuity of care and appropriate follow-up.

As part of the American University of Beirut Medical Center, we are committed to meeting the educational needs of our community. For patients and families, we hold seminars on ILD and offer a support group for anyone affected by this condition. For doctors and other health care providers, we will offer continuing medical education sessions on interstitial lung disease as well as a quarterly newsletter.


​Scope of Patients Who Can Benefit from the Service

The Interstitial Lung Disease Outpatient Center specializes in diagnosing and treating the full spectrum of interstitial lung diseases, including:

  • Pulmonary fibrosis
  • Sarcoidosis
  • Hypersensitivity pneumonitis
  • Occupational lung disease
  • Other disorders such as lymphangioleiomyomatosis (LAM), Langerhans cell histiocytosis (LCH) and cryptogenic organizing pneumonia (COP)

We have the multifaceted expertise to diagnose and treat the various forms of interstitial lung diseases. Equally important, we have the ability to address the complications of these disorders (e.g. pulmonary hypertension) that can greatly compromise quality of life. And patients have the convenience of receiving all their care in one hospital.

We deliver exceptional clinical care and offer patients the opportunity to participate in clinical trials of new therapies and scientific investigations into the causes of interstitial lung diseases.